-
AZ's 'blockbuster' lung cancer drug fails, Q2 revenue falls
pharmafile
July 28, 2017
Imfinzi and immune checkpoint blocker tremelimumab were no better at stopping lung cancer progression than standard chemotherapy in patients expressing protein PD-L1 in over 25% of their cancer cells.
-
New research reveals genetic mutations in smoking-related cancers
pharmafile
July 28, 2017
Researchers at the Wake Forest School of Medicine in the US have made a big discovery which could help explain the role of gene mutations in smoking-related cancers and why
-
Blow for AstraZeneca as cancer combination fails
pharmaphorum
July 27, 2017
After several years of growing expectation, AstraZeneca’s long-awaited MYSTIC immune-oncology trial has failed to show benefit over standard lung cancer therapy.
-
US, EU filings for Eisai’s lenvatinib in liver cancer
pharmatimes
July 27, 2017
Eisai has filed its anticancer drug lenvatinib for liver cancer on both sides of the Atlantic as it seeks to expand the drug’s list of approved uses.
-
Roche antibody becomes first of its kind authorised for blood cancer
pharmafile
July 27, 2017
NICE has announced its decision to make Roche’s Gazyvaro available via the Cancer Drugs Fund (CDF) in combination with chemotherapy for the treatment of follicular lymphoma
-
Sandoz expands partnership with World Child Cancer, to help children access treatment in four develo
worldpharmanews
July 27, 2017
eading charity World Child Cancer, aimed at improving access to treatment and optimizing survival outcomes for children suffering from cancer in four developing countries.
-
Uncovering the cause of immunotherapy resistance in tumours
europeanpharmaceuticalreview
July 27, 2017
Scientists have uncovered a key factor in the development of immunotherapy resistance in the case of cutaneous melanoma. This could potentially lead to future improvements in cancer therapy.
-
Patients at risk as UK plans to leave Euratom
europeanpharmaceuticalreview
July 27, 2017
The UK’s proposed withdrawal from Euratom may threaten the supply of essential medical isotopes, putting cancer patients at risk…
-
Sandoz expands partnership with World Child Cancer
biospectrumasia
July 27, 2017
The expanded partnership highlights Sandoz's commitment to work together with key stakeholders worldwide to expand access to healthcare.
-
NovellusDx collaborates with Gene Editing Institute
biospectrumasia
July 26, 2017
The technology is expected to aid in identifying genetic mechanisms involved in the onset and progression of various cancer types, as well as establish high-efficacy therapy for the disease.